Figure 8.
Correlation of MK3 expression with PD-1, PD-L1, and CTLA-4 in glioma. (A–C) Correlation of MK3 expression with PD-1 (A), PD-L1 (B), and CTLA-4 (C) in GBM adjusted by tumor purity using TIMER. (D–F) Correlation of MK3 expression with PD-1 (D), PD-L1 (E), and CTLA-4 (F) in LGG adjusted by tumor purity using TIMER. (G–I) The expression correlation of MK3 with PD-1 (G), PD-L1 (H), and CTLA-4 (I) in GBM and LGG samples from TCGA dataset. GBM, glioblastoma; TIMER, Tumor IMmune Estimation Resource; LGG, low-grade glioma; TCGA, The Cancer Genome Atlas.